MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 64 filers reported holding MERUS N V in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 893,527 | $23,625,000 | 21.94% |
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $42,304,000 | 11.46% |
COMMODORE CAPITAL LP | 1,816,421 | $48,026,000 | 10.73% |
MPM BioImpact LLC | 919,482 | $24,311,000 | 6.52% |
Aquilo Capital Management, LLC | 1,261,534 | $33,355,000 | 4.90% |
BVF INC/IL | 4,135,071 | $109,331,000 | 4.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 324,719 | $8,586,000 | 3.55% |
TCG Crossover Management, LLC | 300,000 | $7,932,000 | 3.18% |
ACUTA CAPITAL PARTNERS, LLC | 235,500 | $6,227,000 | 2.91% |
Opaleye Management Inc. | 338,000 | $8,937,000 | 2.78% |